RxDoctor Payments Data

Arpit Chhabra, MD

Radiation Oncology · Baltimore, MDNPI 1396006599

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $82,982 of the $97,232 with a category attached, or 85.3%. Icotec Medical Inc. accounts for 98.8% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $35,039, more than ten times the $698 reported in 2019. Among radiation oncology clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$97,232in general payments, 2019–2025

Across 110 payments — averaging $883.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Icotec Medical Inc.$96K
  • Raysearch Laboratories AB (publ)$485
  • Siemens Medical Solutions USA, Inc.$303
  • Novartis$142
  • Ion Beam Applications S.A.$51
  • Teleflex LLC$35
  • plus $103 from 5 others

What the payments were for

  • Consulting fees$82,98285%
  • Travel & lodging$9,99510%
  • Food & beverage$4,2564%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$97,232 in reported general payments places this provider in the 95th percentile of 108 radiation oncology providers in Maryland.

See all radiation oncology providers in Maryland

Medicare billing

Part B allowed, 2024
$629,273
Medicare patients
247
Services billed
1,849

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →